Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG)

M.P. Mehta; M. Won; E.G. Shaw; J. Buckner; M. Gilbert; G. Barger; S. Coons; P. Ricci; D. Bullard; P.D. Brown; K. Stelzer; D.G. Brachman; J.H. Suh; C. Schultz; J. Bahary; B.J. Fisher; H. Kim; A.D. Murtha; W.J. Curran

doi:10.1016/j.ijrobp.2014.05.153

Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG)

M.P. Mehta
, M. Won
, E.G. Shaw
, J. Buckner
, M. Gilbert
, G. Barger
, S. Coons
, P. Ricci
, D. Bullard
, P.D. Brown
, K. Stelzer
, D.G. Brachman
, J.H. Suh
, C. Schultz
, J. Bahary
, B.J. Fisher
, H. Kim
, A.D. Murtha
, W.J. Curran

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	International Journal of Radiation Oncology Biology Physics
Volume	90
DOIs	https://doi.org/10.1016/j.ijrobp.2014.05.153
State	Published - Jan 9 2014

Disciplines

Radiology
Medicine and Health Sciences
Oncology
Immunology and Infectious Disease

Access to Document

10.1016/j.ijrobp.2014.05.153License: Unspecified

Cite this

Mehta, M. P., Won, M., Shaw, E. G., Buckner, J., Gilbert, M., Barger, G., Coons, S., Ricci, P., Bullard, D., Brown, P. D., Stelzer, K., Brachman, D. G., Suh, J. H., Schultz, C., Bahary, J., Fisher, B. J., Kim, H., Murtha, A. D., & Curran, W. J. (2014). Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG). International Journal of Radiation Oncology Biology Physics, 90. https://doi.org/10.1016/j.ijrobp.2014.05.153

Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG). / Mehta, M.P.; Won, M.; Shaw, E.G. et al.
In: International Journal of Radiation Oncology Biology Physics, Vol. 90, 09.01.2014.

Research output: Contribution to journal › Article › peer-review

Mehta, MP, Won, M, Shaw, EG, Buckner, J, Gilbert, M, Barger, G, Coons, S, Ricci, P, Bullard, D, Brown, PD, Stelzer, K, Brachman, DG, Suh, JH, Schultz, C, Bahary, J, Fisher, BJ, Kim, H, Murtha, AD & Curran, WJ 2014, 'Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG)', International Journal of Radiation Oncology Biology Physics, vol. 90. https://doi.org/10.1016/j.ijrobp.2014.05.153

Mehta MP, Won M, Shaw EG, Buckner J, Gilbert M, Barger G et al. Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG). International Journal of Radiation Oncology Biology Physics. 2014 Jan 9;90. doi: 10.1016/j.ijrobp.2014.05.153

@article{ace8cd872a6a49bfaa28291ab84bd721,

title = "Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG)",

author = "M.P. Mehta and M. Won and E.G. Shaw and J. Buckner and M. Gilbert and G. Barger and S. Coons and P. Ricci and D. Bullard and P.D. Brown and K. Stelzer and D.G. Brachman and J.H. Suh and C. Schultz and J. Bahary and B.J. Fisher and H. Kim and A.D. Murtha and W.J. Curran",

note = "Author Disclosure: M.P. Mehta: E. Research Grant; Novocure. F. Honoraria; Research to Excellence, Soreno Foundation. G. Consultant; Abbvie, BMS, Elekta, Merck, Novocure, Novelos, Phillips. I. Travel Expenses; Abbvie, Celldex, Elekta, Phillips, Roche. K. Advisory Board; Celldex, Roche. N. Stock Options; Pharmacyclics, Accuray. P. Royalty; Demos. S. Leadership; RTOG. M. Won: None.",

year = "2014",

month = jan,

day = "9",

doi = "10.1016/j.ijrobp.2014.05.153",

language = "American English",

volume = "90",

journal = "International Journal of Radiation Oncology Biology Physics",

}

TY - JOUR

T1 - Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG)

AU - Mehta, M.P.

AU - Won, M.

AU - Shaw, E.G.

AU - Buckner, J.

AU - Gilbert, M.

AU - Barger, G.

AU - Coons, S.

AU - Ricci, P.

AU - Bullard, D.

AU - Brown, P.D.

AU - Stelzer, K.

AU - Brachman, D.G.

AU - Suh, J.H.

AU - Schultz, C.

AU - Bahary, J.

AU - Fisher, B.J.

AU - Kim, H.

AU - Murtha, A.D.

AU - Curran, W.J.

N1 - Author Disclosure: M.P. Mehta: E. Research Grant; Novocure. F. Honoraria; Research to Excellence, Soreno Foundation. G. Consultant; Abbvie, BMS, Elekta, Merck, Novocure, Novelos, Phillips. I. Travel Expenses; Abbvie, Celldex, Elekta, Phillips, Roche. K. Advisory Board; Celldex, Roche. N. Stock Options; Pharmacyclics, Accuray. P. Royalty; Demos. S. Leadership; RTOG. M. Won: None.

PY - 2014/1/9

Y1 - 2014/1/9

UR - http://www.sciencedirect.com/science/article/pii/S0360301614008049

U2 - 10.1016/j.ijrobp.2014.05.153

DO - 10.1016/j.ijrobp.2014.05.153

M3 - Article

VL - 90

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

ER -

Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG)

Disciplines

Access to Document

Other files and links

Cite this